This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Care REIT, Inc. Announces Pricing Of $1.2 Billion Of Senior Unsecured Notes

Health Care REIT, Inc. (NYSE:HCN) today announced that it has priced $1.2 billion in aggregate principal amount of senior unsecured notes issued in the following tranches:
  • $450 million of 2.25% notes due March 15, 2018 priced to yield 2.350%
  • $500 million of 3.75% notes due March 15, 2023 priced to yield 3.792%
  • $250 million of 5.125% notes due March 15, 2043 priced to yield 5.184%

Subject to customary closing conditions, the offering is expected to close on December 6, 2012.

The company intends to use the net proceeds from this offering to repay certain secured indebtedness to be assumed in connection with the previously announced acquisition of Sunrise Senior Living, Inc. If the acquisition of Sunrise is not completed, or if proceeds remain following repayment of such secured indebtedness, the company intends to use such proceeds for general corporate purposes, including investing in health care and seniors housing properties. Pending such use, the net proceeds may be invested in short-term, investment grade, interest-bearing securities, certificates of deposit or indirect or guaranteed obligations of the United States.

BofA Merrill Lynch, Deutsche Bank Securities, UBS Investment Bank, Citigroup, and Credit Agricole CIB acted as joint book-running managers for the offering.

The offering is being made pursuant to Health Care REIT’s effective shelf registration statement on file with the Securities and Exchange Commission. A copy of the prospectus supplement and accompanying base prospectus relating to the offering may be obtained by contacting Merrill Lynch, Pierce, Fenner & Smith Incorporated, 222 Broadway, 11th Floor, New York, NY 10038, Attention: Prospectus Department or by calling (800) 294-1322; Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, NY 10005 or by calling (800) 503-4611; or UBS Securities LLC, Attention: Prospectus Specialist, 299 Park Avenue, New York, NY 10171, or by calling (877) 827-6444, ext. 561 3884.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,678.87 -51.24 -0.29%
S&P 500 2,072.64 -4.14 -0.20%
NASDAQ 4,997.5520 -11.6620 -0.23%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs